Understanding that the research should continue, the "barrier effect" produced by PAPILOCARE® allows contemplating the possibility of using it in patients with alterations of cervical epithelization to hinder the integration of HPV and prevent infection.

Dr. Javier Cortés


- Senior Consultant in Gynecology Oncology. 

- President of Eurogin 2015. 

- Former President of the Spanish Association 

  of Cervical Pathology and Colposcopy 

  (Palma de Mallorca).

Dr. Damián Dexeus


- Specialist in gynecology and obstetrics. 

- (Women’s Carmona Dexeus).

It is therefore hypothesized that through this multiple actions positively interfering with the three modifiable factors of the HPV clearance, this gel could facilitate the clearance of HPV and prevent its integration into cellular DNA. 

Dr. Luis Serrano


- Specialist in gynecology and obstetrics. 

- Medical Office Velázquez (Madrid).

PAPILOCARE® is an important step for patients with HPV infection, a therapeutical area that does not have many therapeutic solutions.